← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
3M's former health care arm sold its filtration business for $4.0 billion and cut debt 37.1%, but cash from operations fell 68.9% as separation costs ran through the year.
The read at a glance✓ Audited against SEC data
- Growth — Revenue +0.9% to $8.32B; organic growth 3.3%Note
- Profitability — Operating income $2.18B includes a $1,549M sale gainWatch
- Balance sheet — Debt cut 37.1% to $5,035M after the saleOK
- Accounting quality — Safe-zone distress score, no manipulation flagOK
- Capital allocation — Free cash flow -$10M; $1B buyback authorized, none boughtNote
- Separation from 3M — Gross margin -218 bps on tariffs and 3M supply costsWatch
Business
Solventum is the health care business 3M spun off on April 1, 2024. It makes surgical, infection-prevention and wound-care products (MedSurg, 57.9% of 2025 sales), dental and orthodontic products, and revenue-cycle software for hospitals (Health Information Systems). 2025 net sales were $8.32B.
Where the revenue comes from
Fiscal 2025, as Solventum Corp reports it. History and quarterly detail are in the app.
- MedSurg$4.8B
- Health Information Systems$1.4B
- Dental Solutions$1.3B
- Purification and Filtration$497.0M
Leadership changes
From Solventum Corp's own filings, the day they're filed.
- Heather Knight · Chief Commercial Officer · appointmenteff. 2025-11-10
- Control Protection Period · departure
- Participant's Qualifying Termination · departure
Latest filings
- 10-Q · Quarterly report2026-08-05
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-08-05
- 8-K · Company announcement2026-07-20
- 8-K · Company announcement2026-06-05
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Solventum Corp, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.